Novo Nordisk blamed its lower sales forecast on competition from copycat versions of its anti-obesity drugs in the United States.
Photo: Armend NIMANI / AFP/File
Source: AFP
Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy,…
Weight-loss drugmaker Novo Nordisk slims sales forecast …C0NTINUE READING HERE >>>>